retatrutide phase 2 nejm 2023 obesity trial results 🤔 Adults with type diabetes (T2D) and lose less weight on EVERY GLP-1 drug compared to those without diabetes, consistently ~5% less. Now that we have retatrutide's TRIUMPH-2 data today 💉 Retatrutide may be redefining

Weeks 13 through 18: 8mg weekly The jump to 8mg is where the conservative schedule provides the most benefit

At $49.99/year, it's worth it if you need comprehensive shot tracking with injection site rotation, side effect monitoring with correlation reports, Apple Health integration, and prefer native mobile apps

While there has been no change in law, CMS clarified that anti-obesity medications (AOMs) that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use

This is a key part of how to dose peptides

Below are some common goals that L-carnitine supplementation might help with: 1